Jonathan Shaw is Managing Editor. University Finances | 2.3.2022 Climate-Solutions Investments Near 1 Percent of Endowment Assets Harvard Management Company details holdings in second climate report. Health & Medicine | 2.2.2022 Does Omicron Cause “Mild” COVID-19? New evidence suggests the threat of severe infections. University News | 2.1.2022 The Legal Landscape for Climate Change Jody Freeman on the possibilities for federal action Health & Medicine | 1.24.2022 Omnibus Omicron Intelligence Harvard Medical School experts on viral evolution, vaccines, the immune system—and what’s next Faculty & Research | 1.13.2022 Epstein-Barr Virus Implicated as Cause of Multiple Sclerosis Harvard researchers uncover powerful association between EBV and MS, raising hopes for prevention or a cure. Health & Medicine | 12.15.2021 A Surge on Top of a Surge Rising cases on campus—and in communities worldwide Right Now | January-February 2022 Your Brain on Exercise The hormone irisin, promising as a therapeutic against Alzheimer’s and dementia, is responsible for the cognitive benefits of exercise. Features | January-February 2022 Reporting, with an M.B.A. Charles Duhigg unpacks how individuals and organizations work at war, on Wall Street, and in Silicon Valley Right Now | January-February 2022 The Saving Glut of the Rich High savings rates among the wealthiest U.S. earners may represent a macroeconomic risk University News | 12.7.2021 Chan Zuckerberg Commits $500 Million to Harvard Neuroscience and AI Institute A 15-year investment in biomedical and applied science research Health & Medicine | 12.1.2021 Moderna’s Vaccine More Effective than Pfizer’s A head-to-head comparison in 440,000 vaccinated veterans finds Moderna’s vaccine is slightly more effective than Pfizer’s at preventing a range of COVID-19 outcomes. John Harvard's Journal | November-December 2021 Elevating Climate Issues Bacow names economist James Stock to a new position, Vice Provost for Climate and Sustainability Load More
